Enabling CDMOs to Focus on Core Priorities
Synopsis
The biopharmaceutical market's rapid growth has led drug innovators to increasingly rely on CDMOs, with the sector expected to achieve an 11.3% CAGR by 2024. CDMOs must optimize manufacturing and speed-to-market while outsourcing non-core tasks like supply chain management and buffer preparation. Collaborations with industry leaders like Thermo Fisher Scientific offer tailored, end-to-end solutions that streamline workflows, reduce operational costs, and eliminate capital expenditures. These collaborations ensure just-in-time delivery and leverage process liquid/buffer solutions.
Feature:
- End-to-End Supply Chain Solutions: CDMOs can leverage specialized partners like Thermo Fisher Scientific for full supply chain support, including just-in-time (JIT) delivery of quality-controlled materials.
- Customized Chemical Solutions: Workflow solutions include customer-specified pre-made liquid formulations and trusted-weight dry powders.
- Operational Efficiency and Cost Reduction: By outsourcing non-core pre-production activities, CDMOs can reduce the total cost of ownership of raw materials, lower operational expenditures (OpEX), and minimize capital expenditures (CapEX) on equipment and facilities.
- Process Mapping and Lean Principles: Implementing a detailed analysis of pre-manufacturing workflows through Gemba Walks and applying Lean principles help identify bottlenecks and streamline processes.
- Focus on Core Activities: Outsourcing supply chain and buffer preparation allows CDMOs to concentrate on their primary mission-optimizing the drug manufacturing process, improving speed-to-market, and delivering innovative medicines.